- Home
- VANI vs ITIC Comparison
VANI vs ITIC Comparison
Compare VANI & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VANI | ITIC |
|---|---|---|
| Founded | 1998 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.2M | 517.1M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | VANI | ITIC |
|---|---|---|
| Price | $1.35 | $251.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 197.0K | 19.3K |
| Earning Date | 11-13-2025 | 02-12-2026 |
| Dividend Yield | N/A | ★ 6.30% |
| EPS Growth | N/A | ★ 25.81 |
| EPS | N/A | ★ 19.00 |
| Revenue | N/A | ★ $273,864,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $13.23 |
| Revenue Growth | N/A | ★ 13.63 |
| 52 Week Low | $0.91 | $190.20 |
| 52 Week High | $1.92 | $288.98 |
Technical Indicators
Market Signals| Indicator | VANI | ITIC |
|---|---|---|
| Relative Strength Index (RSI) | 42.03 | 44.53 |
| Support Level | $1.36 | $250.26 |
| Resistance Level | $1.46 | $260.66 |
| Average True Range (ATR) | 0.09 | 7.32 |
| MACD | -0.00 | 0.30 |
| Stochastic Oscillator | 4.00 | 51.41 |
Price Performance
Historical ComparisonAbout VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.